|
Market Closed -
Nasdaq
01:30:00 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 31.18 USD | -1.73% |
|
-7.23% | -6.25% |
| 24/08 | Top Midday Decliners | MT |
| 24/08 | Azenta Names Board Member Martin Madaus as Interim CEO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZENTA, INC. | Other Biotechnology & Medical Research | -1.73% | -7.23% | -6.25% | +6.16% | -63.60% | 136.59Cr |  |  | |
- Stock Market
- Stocks
- AZTA Stock
- Charts Azenta, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
